Last reviewed · How we verify
SODIUM PHOSPHATE P 32
SODIUM PHOSPHATE P 32 is a drug. It is currently FDA-approved (first approved 1957).
At a glance
| Generic name | SODIUM PHOSPHATE P 32 |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1957 |
Approved indications
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SODIUM PHOSPHATE P 32 CI brief — competitive landscape report
- SODIUM PHOSPHATE P 32 updates RSS · CI watch RSS
Frequently asked questions about SODIUM PHOSPHATE P 32
What is SODIUM PHOSPHATE P 32?
SODIUM PHOSPHATE P 32 is a Small molecule drug.
When was SODIUM PHOSPHATE P 32 approved?
SODIUM PHOSPHATE P 32 was first approved on 1957.
What development phase is SODIUM PHOSPHATE P 32 in?
SODIUM PHOSPHATE P 32 is FDA-approved (marketed).